We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

In-Vitro Diagnostic Substance Manufacturing (NAICS code 325413) has an average growth rate of 0.87% as an H1B industry with 322 employees hired as of 2024


Top In-Vitro Diagnostic Substance Manufacturing Employers

Company Employees Average Wage
Teco Diagnostics 3 $77,522
Alere, Inc. 2 $157,518
Amt Scientific, Llc 2 $84,760
Ansh Labs Llc 2 $67,476
Atantares Corp 2 $98,842
Azer Scientific, Inc. 2 $54,330
Biolife Solutions Inc. 2 $61,901
Calbiotech Inc 2 $47,185
Group K Diagnostics, Inc 2 $80,164
Immuno-mycologics, Inc. 2 $51,064


Top In-Vitro Diagnostic Substance Manufacturing Jobs

Employees Over Time vs Average Salary Over Time

The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2011 where 6 employees were hired. They peaked in 2023 with 43 employees, and the recent trend shows the average number of employees on an incline.
The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2011 where the average salary was $49,299. The industry peaked in 2023 with an average salary of $97,967, and the recent trend shows the average salary on an incline.